510(k) · Radiology

Sonio Detect

by Sonio

Sonio Detect is an AI-enabled medical device from Sonio that the U.S. FDA cleared through 510(k) K230365 on July 25, 2023. Its lead review panel is Radiology and its primary product code is IYN (System, Imaging, Pulsed Doppler, Ultrasonic).

See also FDA-cleared AI radiology devices in 2023, all FDA AI clearances in 2023, top radiology AI devices.

Key facts

Submission numberK230365
Pathway510(k)
Date of final decision
Company (FDA list)Sonio
Lead review panelRadiology
Primary product codeIYN — System, Imaging, Pulsed Doppler, Ultrasonic
Applicant (openFDA)Sonio
Applicant locationParis, FR
Device classClass 2
Regulation number21 CFR 892.1550
Decision codeSESE
Submission typeTraditional

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. Sonio Detect went through this pathway (K230365).

openFDA lists it as a Class 2 device under 21 CFR 892.1550. Class II devices are moderate risk and are subject to general and special controls.

Product code IYN covers 124 devices on the FDA AI list. By decision date, this device is #46 of 124 under that code. Sonio has 5 AI-enabled devices on the list, and the Radiology panel accounts for 1,230 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code IYN)

More from Sonio